These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24852924)

  • 1. Depression in multiple sclerosis: a long-term longitudinal study.
    Koch MW; Patten S; Berzins S; Zhornitsky S; Greenfield J; Wall W; Metz LM
    Mult Scler; 2015 Jan; 21(1):76-82. PubMed ID: 24852924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study.
    Koch M; Mostert J; Heerings M; Uyttenboogaart M; De Keyser J
    Eur J Neurol; 2009 Mar; 16(3):348-52. PubMed ID: 19490071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study.
    Janssens AC; Buljevac D; van Doorn PA; van der Meché FG; Polman CH; Passchier J; Hintzen RQ
    Mult Scler; 2006 Dec; 12(6):794-801. PubMed ID: 17263009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in Iranian patients with multiple sclerosis: a cross-cultural study.
    Pakpour AH; Yekaninejad MS; Mohammadi NK; Molsted S; Zarei F; Patti F; Harrison A
    Neurol Neurochir Pol; 2009; 43(6):517-26. PubMed ID: 20054754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.
    Dahl OP; Stordal E; Lydersen S; Midgard R
    Mult Scler; 2009 Dec; 15(12):1495-501. PubMed ID: 19965515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms in a treated multiple sclerosis cohort.
    Patten SB; Fridhandler S; Beck CA; Metz LM
    Mult Scler; 2003 Dec; 9(6):616-20. PubMed ID: 14664476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up.
    Giordano A; Ferrari G; Radice D; Randi G; Bisanti L; Solari A;
    Eur J Neurol; 2013 Apr; 20(4):681-8. PubMed ID: 23217086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
    Sjonnesen K; Berzins S; Fiest KM; M Bulloch AG; Metz LM; Thombs BD; Patten SB
    Postgrad Med; 2012 Sep; 124(5):69-77. PubMed ID: 23095427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.
    Lobentanz IS; Asenbaum S; Vass K; Sauter C; Klösch G; Kollegger H; Kristoferitsch W; Zeitlhofer J
    Acta Neurol Scand; 2004 Jul; 110(1):6-13. PubMed ID: 15180801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following surgical management of coexistent cervical stenosis and multiple sclerosis: a cohort-controlled analysis.
    Lubelski D; Abdullah KG; Alvin MD; Wang TY; Nowacki AS; Steinmetz MP; Ransohoff RM; Benzel EC; Mroz TE
    Spine J; 2014 Feb; 14(2):331-7. PubMed ID: 24239804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of multiple sclerosis in Lebanon.
    Yamout B; Itani S; Arabi A; Hamzeh D; Yaghi S
    Int J Neurosci; 2010 Mar; 120(3):206-10. PubMed ID: 20374088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
    Enzinger C; Fuchs S; Pichler A; Wallner-Blazek M; Khalil M; Langkammer C; Ropele S; Fazekas F
    Mult Scler; 2011 Jun; 17(6):695-701. PubMed ID: 21228028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign multiple sclerosis: a new definition of this entity is needed.
    Correale J; Peirano I; Romano L
    Mult Scler; 2012 Feb; 18(2):210-8. PubMed ID: 21865415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.